Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trialsPaul E. Sax, David A. Wohl, Anton Pozniak et al.|EClinicalMedicine|2023Cited by 90
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trialAnchalee Avihingsanon, Taisheng Li, Hongzhou Lu et al.|The Lancet HIV|2023Cited by 62